This may change in the future to be a full diagnosis when combined with a device such as Fitbit which have blood oxygen sensors build in and awaiting FDA approval. Combining both data sets may be more of a comparison to the gold standard. But in the mean time they can market this and begin generating revenue so I can't see it as a bad thing. Could have been better yes.....but this is still positive and can be improved on down line.
- Forums
- ASX - By Stock
- Ann: ResApp Announces SleepCheck, a Sleep Apnoea Screening App
This may change in the future to be a full diagnosis when...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)